[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …

DO Kleindorfer, A Towfighi, S Chaturvedi, KM Cockroft… - Stroke, 2021 - journals.lww.com
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

SL Mackie, C Dejaco, S Appenzeller… - …, 2020 - academic.oup.com
Background GCA is a large vessel vasculitis affecting older people, with the highest
incidence among persons 70–79 years of age [1]. Due to forecasted demographic changes …

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

B Hellmich, A Agueda, S Monti, F Buttgereit… - Annals of the …, 2020 - ard.bmj.com
Background Since the publication of the European League Against Rheumatism (EULAR)
recommendations for the management of large vessel vasculitis (LVV) in 2009, several …

The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease

C Dejaco, C Duftner, F Buttgereit, EL Matteson… - …, 2017 - academic.oup.com
GCA and PMR are conditions of older persons that frequently overlap. The traditional
concept of GCA has focused on cranial symptoms such as headache and visual …

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

C Dejaco, A Kerschbaumer, D Aletaha… - Annals of the …, 2024 - ard.bmj.com
Objectives To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and
polymyalgia rheumatica (PMR). Methods A systematic literature review was conducted to …

Polymyalgia rheumatica and giant-cell arteritis

C Salvarani, F Cantini, GG Hunder - The Lancet, 2008 - thelancet.com
Polymyalgia rheumatica and giant-cell arteritis are closely related disorders that affect
people of middle age and older. They frequently occur together. Both are syndromes of …

EULAR recommendations for the management of large vessel vasculitis

C Mukhtyar, L Guillevin, MC Cid, B Dasgupta… - Annals of the …, 2009 - ard.bmj.com
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of large vessel vasculitis. Methods: An expert group (10 …

Polymyalgia rheumatica and giant-cell arteritis

C Salvarani, F Cantini, L Boiardi… - New England Journal of …, 2002 - Mass Medical Soc
Polymyalgia rheumatica is an inflammatory disorder manifested principally by stiffness of the
neck, shoulder girdle, and pelvic girdle; giant-cell (or temporal) arteritis affects the cranial …

A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis

GS Hoffman, MC Cid, DB Hellmann… - Arthritis & …, 2002 - Wiley Online Library
Objective To evaluate treatment with methotrexate (MTX) in patients with newly diagnosed
giant cell arteritis (GCA) to determine if MTX reduces GCA relapses and cumulative …

Ophthalmic manifestations of giant cell arteritis

I Vodopivec, JF Rizzo III - Rheumatology, 2018 - academic.oup.com
GCA, the most common systemic arteritis, affects medium-sized and larger extradural
arteries that have the internal elastic lamina. Involvement of the ophthalmic artery and its …